EADV Podcast

EADV•eadv.podbean.com

The official podcast of the European Academy of Dermatology and Venereology. Newest research in dermatology and venereology, interviews with notable doctors, professors and researchers: a focused look on today’s dermatology and venereology and new developments moving towards the future.

Last refreshed: July 8th, 2025 at 3:10 PM ⓘ

Follow this podcast in the Metacast mobile app to refresh it and see new episodes.

Follow on

Apple Podcasts

Spotify

RSS

Podcasts are better in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

E51: Patient Advocacy in Hidradenitis Suppurativa: How Deep Patients’ Scars Run in this Difficult-to-Treat Condition?

This week Prof. Christos Zouboulis from the Dessau Medical Center interviews Bente Villumsen, the President of the Patientforeningen HS Danmark (Danish Hidradenitis Suppurativa Patient Association). They discuss the importance of increasing disease awareness, availability of reliable medical information incorporating the patient perspective and establishing a meaningful cooperation between patients, their treating dermatologists as well as the industry. Not an EADV Member? Click Here for more in...

Feb 01, 2022•32 min•Ep. 51

E50: Editor’s Picks January 2022

Join us as we go through the JEADV Editor's Picks of January 2022: (1) Dermatologic origin of a fatal C. ciferrii systemic infection (2) Emollient use in hot environments among neonates for eczema prevention: how much is enough? (3) Non-invasive visualization of human skin (4) Acute self-limiting erythema multiforme after SARS-CoV-2 vaccination Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17818

Jan 18, 2022•9 min•Ep. 50

E49: Insights into Paediatrics Dermatology from the first-ever JEACP Editor-in-Chief

This week JEADV Clinical Practice Editor-in-Chief Dr. Antonio Torrelo talks about his three decades of experience in Paediatrics Dermatology, highlighting the most important skills and challenges of treating children with skin diseases. Moreover, Dr. Torrelo shares some key facts about JEACP and reveals how a day in the life of the Editor of EADV's new Open Access journal looks like. Visit https://bit.ly/EADV_JEACP to learn more about JEADV Clinical Practice...

Jan 11, 2022•27 min•Ep. 49

E48: Cosmetic Dermatology: Challenging Situations Part 2

This week Prof. Ashraf Badawi covers more topics connected with challenging situations in cosmetic dermatology. In this second episode of a two-part- series he discusses laser and light-based therapies and injectables in autoimmune diseases, particularly Lupus and considers how to, and when not to, treat patients with psychological disorders seeking aesthetic procedures. He brings practical clinical experience as well as the current research to the discussion. Not an EADV Member? Click Here for ...

Jan 04, 2022•16 min•Ep. 48

E47: Editor’s Picks December 2021

Join us as we go through the JEADV Editor's Picks of December 2021: (1) Skin conditions affect politicians too (2) Evaluating a chemical peel, non-invasively (3) SARS-CoV-2 transmission via sweat: searching for evidence (4) Undertreatment of scabies Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17763

Dec 21, 2021•9 min•Ep. 47

E46: The Role Of Autoantibodies In Itchy And Blistering Diseases

Could better understanding of the role of autoantibodies hold the key to personalised treatments in itchy and blistering diseases? This week we bring together experts Prof. Kridin and Dr. Meijer to discuss their recent JEADV publications concerning the role of autoantibodies in itchy and blistering diseases. Prof. Kridin talks about the pathophysiology and therapeutic approaches to treat patients with bullous pemphigoid and comorbid psoriasis, followed by Dr. Meijer’s explanation regarding the r...

Dec 14, 2021•26 min•Ep. 46

E45: Cosmetic Dermatology: Challenging Situations Part 1

Should you stop an anticoagulant for thrombosis to prevent bruising after cosmetic procedures? What changed during the pandemic? Can ablative laser plumes harm operating room personnel? This week Prof. Ashraf Badawi discusses challenging situations that can arise in cosmetic dermatology. He brings practical clinical experience as well as the current research to the discussion. Not an EADV Member? Click Here for more information on the advantages and opportunities that only EADV Members have- inc...

Dec 07, 2021•14 min•Ep. 45

E44: Editor’s Picks November 2021

Join us as we go through the JEADV Editor's Picks of November 2021: (1) Long-term safety data for a monoclonal antibody used in psoriasis (2) Preventing anaphylactoid symptoms following Covid-19 vaccination (3) Innovative surgery option for bromhidrosis (4) Surprising trends in syphilis Read the editor's picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17691

Nov 23, 2021•11 min•Ep. 44

E43: The Evolving Field of Dermato-oncology: A License to Examine

This week EADV Advocacy Working Group Leader Myrto Trakatelli talks with Stella Siskou about topics including EPIDERM, the EADV Advocacy Working Group, and a position paper on the role of dermatologists in the evolving field of Dermato-oncology. The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Force https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16849...

Nov 16, 2021•33 min•Ep. 43

E42: Changing Treatment Landscape in Psoriasis

This week Dr. Mark Lebwohl from Icahn School of Medicine at Mount Sinai joins us to discuss the latest treatment options for psoriasis and his research focusing on new topical therapies for the management of the disease. Links to the six articles discussed can be found here: Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial Secukinumab maintains superiority over us...

Nov 02, 2021•30 min•Ep. 42

← Prev

For the best experience, listen in Metacast app for iOS or Android